SlideShare a Scribd company logo
1 of 44
Anaerobic Gram-Positive Spore-
Forming Bacilli
Clostridium perfringens (Clostridium welchii)
• Gram reaction & characteristics:
• Gram positive or gram variable bacilli, sore forming, obligate anaerobe, non-motile.
brick-shaped rods/box car. Spores rarely seen. Spores are subterminal but difficult to
induce.
• Habitat:
• Common inhabitant of the colon.
• Virulence factor:
• Produces several exotoxins; alphatoxin, the most important, mediates destruction of host
cell membranes; enterotoxin inserts and disrupts membranes of mucosal cells; beta-toxin
is a cytotoxin. Hemolysin, necrotizing toxin.
• Disease:
• Cellulitis, gas gangrene.
• Alpha toxin (lecithinase) → muscle cell necrosis, degradative enzymes → subcutaneous
gas bubbles → crepitus myonecrosis with crepitus (crackles), gangrenous muscles →
black fluid exudate leaking from skin.
• Post-abortion sepsis, abdominal infections, and enterocolitis, septicemia.
• Major cause of food poisoning (from meats and gravy), resulting in a mild to moderate
diarrhea without vomiting.
• Enteritis necroticans (necrotizing enteritis; NEC): Life threatening infection that causes
ischemic necrosis of the jejunum.
• Diabetics and patients with circulatory disorders are more prone to infection.
• Mode of transmission:
• Bacteria are acquired through puncture wound or by ingestion. C. perfringens is normal
flora of the GI tract and can spread from this site following trauma.
• C. perfringens is also normal flora of the female genital tract and can cause post-abortion
infections.
• Lab diagnosis:
• Samples: wound swabs, necrosed tissues, muscle fragments, exudates, pus, stool, food.
• Culture characteristics:
• Dome shape, glossy, dew drop, produces a double zone of beta-hemolysis on SBA or
BRU/BA incubated anaerobically.
• C. perfringens exhibits a positive (enhanced hemolysis) reverse CAMP test. In this
assay, Streptococcus agalactiae (group B streptococci) is substituted for
Staphylococcus aureus in the standard CAMP test.
• Biochemical tests:
• Positive: Positive for lecithinase and glucose, lactose, maltose, and fructose
fermentation. Catalase negative.
• Treatment:
• Surgical removal of infected areas (amputation).
• Hyperbaric oxygen to kill anaerobic organisms.
• Penicillin, clindamycin (effective only in local, weak infections).
• Nagler test:
• Antilecithinase antibody is swabbed onto half of an egg yolk agar plate. The
isolate is inoculated onto both halves of the plate. C. perfringens produces
lecithinase, which will produce an opaque zone on the half of the plate without
the antibody. The antibody will neutralize lecithinase, preventing the opaque
zone from forming. This test is not performed much today.
Clostridium tetani (drum-stick bacillus)
• Gram reaction & characteristics:
• Gram-positive bacilli with round/terminal spores that resemble drumsticks or tennis
racket/lollipop obligate anaerobe, motile. Becomes gram neg after 24 hr.
• Habitat:
• Soil, dust, intestinal tract of various animal.
• Virulence factor:
• Produces tetanospasmin (TeNT), a neurotoxic exotoxin that disrupts nerve impulses to
muscles.
• Disease:
• Spastic paralysis, tetanus (lock jaw or trismus), risus sardonicus (sneering):
• C. tetani produces tetanospasmin, a neurotoxin that affects the anterior horn cells of the
spinal cord, resulting in involuntary muscle contractions. Contractions begin with the
neck and jaw ("lock jaw") and progress to a backward arching of the back muscles.
• Mode of transmission:
• Bacteria and spores gain entry into the host by puncture wounds contaminated with
soil, or by wounds, which may include gunshots, burns, or animal bites. The bacteria
produce little necrosis. Contamination of existing wound or puncture by objects
contaminated with toxigenic Clostridium spp.
• Drug injections. Human & animal bites.
• Lab diagnosis:
• Samples: excised bits of tissue from necrotic depths of wounds. Wounds swabs are not good.
• Culture characteristics:
• Colonies on BRU/BA are irregular and rhizoid, gray, matte, translucent, and usually with a
narrow zone of -hemolysis. Often, a C. tetani colony swarms over the surface of a moist agar
plate (proteus of anaerobe world).
• Biochemical tests:
• Positive: gelatinase, spot indole and motility positive.
• Negative: catalase, lecithinase and lipase negative.
• Treatment:
• Clean wound
• Antitoxin (human anti-tetanospasmin immunoglobulin)
• DTaP vaccine booster
• Penicillin, metronidazole
• Diazepam (a GABA agonist).
• Prophylaxis:
• DTaP vaccine: tetanus toxoid, boosters required.
• Note:
• DTaP vaccines are administered at 2, 4, 6, and 18 months, again before starting school, and
every 10 years thereafter.
• Spores can affect neonates through cut umbilical cord, especially when the mother is not
immunized.
Body posture known as opisthotonos,
caused by the neurotoxin tetanospasmin.
Clostridium botulinum
• Gram reaction & characteristics:
• Gram positive or gram variable, bacilli, spore forming, obligate anaerobe, motile. Spores
are oval/subterminal and resemble tennis rackets.
• Habitat:
• Soil, dust, water, vegetables, animals.
• Virulence factor:
• Botulinal toxin (BoNT), A, B, C, D, E, F ,G is a neurotoxin that binds to the synapse of
nerve fibers (blocks acetylcholine release), resulting in acute (flaccid/rag doll) paralysis
and death.
• Disease:
• Botulism. Flaccid paralysis and the four Ds: diplopia (double vision), dysarthria (speech
disturbance), dysphonia (altered voice), and dysphagia (difficulty swallowing).
• Adult botulism (classical food poisoning). Botulism due to ingestion of toxin in
inadequately cooked or improperly canned foods.
• Infant botulism/intestinal botulism (floppy baby syndrome). Infant botulism (due to
ingestion of spores in honey) is the most common type of botulism. Bacteria are ingested
and grow in the infant GI tract and can cause a rapidly fatal infection.
• Wound botulism is the result of contamination of wounds with spores of C. botulinum,
with subsequent germination, multiplication, and production of botulinal toxin in vivo.
• No fever!
• Mode of transmission:
• Botulism is usually acquired by ingestions of spoiled, home-canned foods in which the
spores are not destroyed.
• Wound botulism from injection drug use.
• Lab diagnosis:
• Samples: stool, wounds specimen, food.
• Botulinal toxin in serum, feces, gastric contents, vomitus, or the implicated food.
• Toxicity in mice.
• Culture characteristics:
• On egg yolk agar (EYA), yellow precipitation, exhibit a pearly surface iridescence as a
result of lipase positivity.
• Biochemical tests:
• Positive: Lipase, glucose, and motility.
• Negative: lecithinase, spot indole, catalase.
• Treatment:
• Antitoxin, respiratory support.
• Note:
• Botulinum toxin has been applied successfully to treat a number of conditions,
including strabismus, muscle spasticity, and facial wrinkles (Botox).
Clostridium difficile
• Gram reaction & characteristics:
• Gram positive bacilli, may arrange in chains (2-6 cells) spore forming (subterminal), obligate
anaerobe, motile. Brick-shaped bacilli
• Habitat:
• C. difficile is normal GI flora in a small percentage of the population, and as many as 30% of
hospitalized patients may carry the bacteria.
• Virulence factor:
• toxin A (TcdA), enterotoxin → alters fluid secretion → watery diarrhea (AAD).
• toxin B (TcdB), cytotoxic to epithelial cells → pseudomembranous colitis.
• Disease:
• Antibiotic treatment disrupts normal flora but C. difficile survives by forming spores.
• Pseudomembranous Colitis (PMC), diarrhea (AAD).
• Mode of transmission:
• Person-to-person spread.
• Spores of C. difficile are frequently transmitted among hospitalized patients and are often
present on the hands of hospital personnel caring for patients.
• Lab diagnosis:
• Stool specimen: stool, toxin B present in feces.
• Colonoscopy: pseudomembranes (yellow-white plaques) present.
• Because C. difficile can be normal flora, stool cultures can sometimes be too sensitive.
Cultures for C. difficile should only be performed on watery or unformed stools.
• It is also important to test isolates for toxin production.
• Samples:
• Culture characteristics:
• Non-hemolytic on BRU/BA.
• Cycloserine-cefoxitin-fructose agar (CCFA) is used for isolating C. difficile from stool
specimens, fructose positive, yellow flattened colonies. The product will also
fluoresce yellow-green.
• Biochemical tests:
• Positive: glucose and fructose fermentation.
• Negative: Lecithinase, lipase, catalase and spot indole.
• Treatment:
• Oral metronidazole or oral vancomycin. Withdraw causative antibiotic (often
clindamycin).
• Note:
• Major cause of hospital-acquired diarrhea, often transmitted by the hands of hospital
personnel. Inflammation by toxin A can sometimes cause hypoalbuminemia.
SPIROCHETES
Treponema pallidum
• Characteristics:
• Spirochetes, long, slender, helically curved bacilli, endoflagella, cannot usually be seen on
Gram stain, microaerophilic, sensitive to high temperature. Special stains such as silver and
Giemsa will stain spirochetes, silver for all spirochetes and Giemsa only for Borrelia.
• Habitat:
• Virulence factor:
• Coat itself with host proteins.
• Tropism to arterioles; infection ultimately leads to endarteritis (inflammation of the lining
of arteries) and subsequent progressive tissue destruction.
• Disease:
• Venereal syphilis, 3 stages:
• Primary: Chancre (painless ulcer) at the site of inoculation (genitalia). The primary stage
is extremely infectious, because the lesion contains a large number of organisms.
• Secondary: Skin rash and lesions on oral mucosa (fever, weight loss, malaise, and loss of
appetite are present). Common symptoms are flulike (fever, sore throat, lymphadenopathy,
Patchy hair loss may occur, such as loss of eyebrows (“moth-eaten” area). highly infectious
state. Aseptic meningitis,
• Latent: Absence of clinical symptoms (subclinical).
• Tertiary: CNS disorders (neurosyphilis), aneurysms, and skin, liver, and bone disorders,
cardiovascular abnormalities, eye disease, and granuloma-like lesions (gummas) that are
soft, painless, and noninfectious and found on the skin or in the bones or visceral organs.
• Congenital syphilis is transmitted from a mother to an unborn fetus during any stage of
infection but is most often associated with early syphilis. The unborn fetus may develop
an asymptomatic infection or symptomatic infection.
• Symptoms known as Hutchinson triad (deafness, blindness, notched peg-shaped teeth)
may occur. Additionally, poor bone formation may result, such as “saber shin” bowing of
the tibia and the “bull dog” appearance of a deformed maxilla. Finally, neurosyphilis or
neonatal death can occur.
• Other clinically important species include T. pallidum subsp. pertenue (yaws), T.
pallidum subsp. endemicum (endemic syphilis), and T. carateum (pinta).
• Mode of transmission:
• Transmitted by sexual contact, direct blood transmission, or transplacentally (congenital
syphilis).
• Lab diagnosis:
• Spirochetes can be observed by darkfield or phase-contrast microscopy.
• Samples: from ulcers, lesions, CSF, umbilical cord section, placenta.
• chancer (containing live spirochetes), for primary syphilis diagnosis.
• Serology:
• Nontreponemal antigen tests include the Venereal Disease Research Laboratory
(VDRL) and rapid plasma reagin (RPR) tests, which detect antibodies to cardiolipin-
lecithin-cholesterol and are nonspecific. These antibodies are sometimes referred to
as reagin. Biologic false positives are caused by Lyme disease, various viruses,
autoimmune disorders (e.g., systemic lupus erythematosus), IM and pregnancy.
• Treponemal antigen tests include the fluorescent treponemal antibody absorption
(FT A-ABS) test and the Treponema pallidum particulate antigen (TP-PA) test,
which are specific and confirmatory.
• Direct fluorescent antibody tests can be used to detect T. pallidum in tissues and
material obtained from primary or secondary lesions.
• Culture characteristics:
• T. pallidum cannot be cultured in the laboratory. The bacteria exhibit corkscrew
motility seen by darkfield microscopy on material taken from lesions.
• T. pallidum subsp. pallidum can be propagated in the testicles of live rabbits.
Treatment:
Penicillin G.
Note:
Organisms that cross placenta and
therefore allow infection to pass from
pregnant mother to fetus (TORCHES):
TOxoplasma gondii
Rubella
Cytomegalovirus
HErpes, HIV
Syphilis
Mycobacterium tuberculosis
• Characteristics:
• Gram positive, acid-fast bacilli, thin rods, non-motile, obligate aerobe. Mycolic acid cell
wall: acid-fast staining, renders cell resistant to phagocytosis, germicides, and dryness.
• Habitat:
• Virulence factor:
• Sulfatides in cell wall inhibit phagosome from fusing to lysosome, facultative I/C.
• Disease:
• Primary tuberculosis:
• Infection begins in the middle or lower areas of the lungs.
• The bacteria can spread (extrapulmonary tubercles) to the lymphatic system
(scrofula), CNS, and heart (pericarditis), vertebral bodies (Pott’s disease), kidneys,
GI.
• Macrophages phagocytize the bacteria and form multinucleated cells, which are
eventually surrounded by fibroid cells. Together the cells form granulomatous lesions
called tubercles, which can be seen on chest X-rays. The lesions can calcify, at which
point they are called "ghon complexes." While the bacteria are contained within the
granulomas, the patient is typically asymptomatic. This stage of the disease is called
a latent infection.
• Primary TB may not lead to active TB in people with healthy immune systems.
• Bloody sputum.
• A mycolic acid in the cell walls of M. tuberculosis, called cord factor, is associated with
several biologic activities, including host cell membrane cytotoxicity and inhibition of
white blood cell migration.
Serpentine cording
Middlebrook 7H10
• Reactivation or secondary tuberculosis:
• Occurs in people who have had latent TB.
• Dormant phase (macrophages) → mycolic acid cell wall allows intracellular survival
and proliferation. Reactivation of pulmonary tubercles, may disseminate to other
sites through lymphatics and blood (miliary TB),
• Reactivation, because of alteration in the cell-mediated immune response, can be
triggered by poor nutrition, alcoholism, or hormonal factors associated with
pregnancy and diabetes.
• Treatment requires long-term combination therapy, which can last up to 24 months.
First-line drugs include isoniazid, rifampin, ethambutol, and pyrazinamide.
• Mode of transmission:
• Spread by person-to-person contact via infected droplets.
special safety precautions must be practiced when working
with mycobacteria
• Negative-pressure room with air exiting through HEPA filters;
• Biosafety cabinet.
• Special centrifuges to contain aerosol production.
• Protective clothing, such as masks, disposable gowns, gloves, caps, shoe protection, and
sometimes, respirators.
• Personnel should be monitored annually with the Mantoux tuberculin test (PPD), in
which a mycobacterial antigen is injected into the skin.
• Lab diagnosis:
• Specimens:
• Lower respiratory tract: Sputum and bronchial washings, usually 3 to 5 samples, are
collected early in the morning on different days.
• Urine: 3 to 5 different morning voids
• Blood and bone marrow.
• Tissue and body fluids.
• It is necessary to decontaminate samples containing normal flora before culturing, and
sputum must also be digested.
• Digestion and decontamination of sputum samples:
• The mycobacteria are slightly more resistant to acids and alkalis than contaminating
bacteria making up the normal flora. Therefore, mild treatments, such as 2% NaOH
with N-acetyl-L-cysteine (NALC), benzalkonium chloride, oxalic acid are effective.
Only specimens containing normal flora, such as sputum that contains bacteria from
the oral cavity or feces, urine, gastric lavage, need to be decontaminated. Specimens
from normally sterile sites (e.g., CSF, blood, etc.) do not require decontamination.
• NALC is a mucolytic agent that liquefies mucus in respiratory specimens,
releasing mycobacteria.
• NaOH is digestant and decontaminating agent, increases the pH to a level that is
antibacterial.
Centers for Disease Control and Prevention acid-fast smear evaluation and reporting criteria
• Solid media:
• Lowenstein-Jensen (LJ) contains egg components for growth and malachite green to
inhibit growth of normal flora (nonpigmented (tan or buff, rough & tough), dry, heaped,
and granular in 14-21 days at 37° C).
• Lowenstein-Jensen-Gruft is made selective by the addition of penicillin and naladixic
acid. It is also supplemented with RNA.
• Middlebrook medium is agar based and contains 2% glycerol to support the growth of M.
aviwn complex (MAC). These media generally exhibit growth several days before egg-
based media. Antimicrobials can be added to make the media selective for the
mycobacteria.
• Liquid media:
• Middlebrook 7H9 broth is often used to maintain stock cultures and prepare isolates for
biochemical tests.
• Mycobacterium growth index tube (MGIT®) by Becton Dickinson (Franklin Lakes, NJ)
contains a modified 7H9 broth. The large amount of oxygen in the broth quenches the
fluorescence of a fluorochrome. As mycobacteria grow, they consume the oxygen, and the
fluorochrome will fluoresce when exposed to ultraviolet light.
• BACTEC 460TB system contains a radioactively labeled substrate that can be metabolized by
mycobacteria. Growth of mycobacteria releases radioactive CO2 that is detected by the
instrument.
+ve niacin accumulation test
(right)
• Acid-fast stain of sputum, PCR.
• Purified protein derivative (PPD) test: DTH reaction in active or previous infection
• Ghon complex on CXR.
• Measure IFN-gamma released by lymphocytes exposed to M. tuberculosis antigens (e. g.,
Quantiferon Gold assay/IGRA).
• Mycobacteria resist Gram staining because of lipids in their cell wall that prevent
penetration of crystal violet and safranin.
• Mycobacteria are acid-fast and are referred to as acid-fast bacilli (AFB). The primary
stain in the acid-fast stain is carbol fuchsin. The Ziehl-Neelsen stain requires heating
during the staining step, whereas the Kinyoun's stain does not.
• M. tuberculosis is niacin positive, nitrate reduction positive, and 68°C catalase test
negative.
• Treatment:
• Multidrug-resistant M. tuberculosis (MDR-TB), defined as simultaneous resistance to
isoniazid and rifampin, was first discovered in 1991, and, if present, indicates a poor
prognosis for recovery.
• Extremely-drug-resistant M. tuberculosis (XDR-TB) is defined as resistance to any
fluoroquinolone, and at least one of three injectable second-line drugs (capreomycin,
kanamycin, and amikacin), in addition to isoniazid and rifampicin.
• Treat with RIPES (multiple drugs to avoid resistance): rifampin, isoniazid, pyrazinamide,
ethambutol, streptomycin prophylaxis (for +ve PPD).
• BCG (Bacille Calmette-Guerin) vaccine: live attenuated vaccine for cell-mediated
immunity, renders patient PPD +ve.
• Mycobacterium avium complex (MAC) is comprised of two species that are difficult to
distinguish, M. avium and M. intracellulare, collectively called Mycobacterium avium-
intracellulare (MAI).
• MAI infections are clinically indistinguishable from pulmonary and systemic tuberculosis
infections. They are a major opportunistic pathogen in AIDS patients with low CD4 counts
and are resistant to multiple drugs.
• Treatment is with a macrolide ( azithromycin or clarithromycin) + ethambutol + rifamycin
(rifampin or rifabutin).
• M. bovis is found in unpasteurized milk and can lead to GI tuberculosis. Alternatively, it can
lead to pulmonary tuberculosis if inhaled.
• +ve PPD test: 10 mm induration (or 5 mm induration if immunocompromised, in AIDS often
false-negative).
• Runyon groups:
• Photoreactivity:
• 1) Photochromogens produce yellow to orange pigment only when exposed to light.
• 2) Scotochromogens produce yellow to orange pigment in the light and in the dark.
• 3) Nonchromogens (nonpigmented) do not produce pigment.
• Growth rate:
• Rapid growers produce colonies on solid media within 1 week. Most common pathogens
are slow growers, and weakly pathogenic species are rapid growers.
• Members of Runyon group 1 are slow growers and photochromogens.
• Group 2 members are slow growers and scotochromogens.
• Mycobacteria that are slow growers and nonchromogens belong to group 3. Group 4
contains the rapidly growing mycobacteria. Because of variation within the species,
Runyon groups are no longer commonly used.
• Niacin
• Niacin (nicotinic acid) is a precursor in the synthesis of NAD. Although all mycobacteria
produce niacin, some species produce an excess amount that is excreted from the cell.
Niacin accumulates in the medium and is detected by reacting with a cyanogen halide.
• M. tuberculosis is one of the few species positive for the accumulation of niacin.
• Growth on MacConkey agar
• MacConkey agar without crystal violet is inoculated with a 7-day broth culture of the
test organism. This is not the same formulation used for gram-negative bacilli.
• M. fortuitum and M. chelonei are the only mycobacteria able to grow on MacConkey agar
in 5 days.
• Susceptibility to thiophene-2-carboxylic acid hydrazide (T2H): differentiates M. bovis
(susceptible) from most other species (resistant).
Acid fast stain
Antimicrobials
• An antibiotic is a molecule produced by microorganisms that inhibits the growth of
other microorganisms. Antibiotics can also be synthetic.
• Cidal: Kills microorganisms (e.g., bactericidal compound kills bacteria).
• Static: Inhibits the growth of microorganisms (e.g., bacteristatic compound inhibits
bacterial growth)
• Synergy: When two or more antimicrobials are used, and the combined effect is greater
than what would be expected for the simple additive effect of the agents.
• Spectrum of Action:
1. Narrow-spectrum antimicrobial agent: Limited range of action
2. Broad-spectrum antimicrobial agent: Active against a wide range of bacteria.
Classes of Antimicrobial Agents and Their Mode of Action
• Beta-lactam antibiotics:
• Inhibit cell wall synthesis.
• (e.g., penicillins, cephalosporins, monobactams, and carbapenems).
• Cephalosporin:
• Narrow spectrum (first generation),
• Expanded spectrum (second generation),
• Broad spectrum (third generation),
• Extended spectrum (fourth generation).
• Beta-lactamase inhibitors:
• Bacteria can exhibit resistance to the beta-lactam antibiotics by producing an enzyme
(beta-lactamase) that cleaves the beta-lactam ring, inactivating the antibiotic.
• Beta-lactamase inhibitors can be given with a beta-lactam antibiotic to provide effective
treatment. Clavulanic acid, sulbactam, and tazobactam are examples of beta-lactamase
inhibitors.
• Aminoglycosides:
• Inhibit protein synthesis at the 30S ribosomal subunit and are
• Active against gram-negative and gram-positive bacteria
• (e.g., gentamicin, tobramycin and netilmicin). Tobramycin is bactericidal whereas the
others are bacteriostatic.
• They have no activity against obligate anaerobes.
• Because of potential toxicity, dosage should be monitored.
• Tetracyclines:
• Inhibit protein synthesis at the 30S ribosomal subunit.
• (e.g., doxycycline and minocycline).
• They are active against gram-positive and gram-negative bacteria and Mycoplasma and
Chlamydia.
• Increased resistance has limited their use.
• Chloramphenicol inhibits protein synthesis by binding to the 30S ribosomal subunit. It
is broad spectrum and used to treat serious gram-negative infections such as meningitis.
Risk of bone marrow toxicity, aplastic anemia (bone marrow suppression), limits use to
serious infections.
• Macrolides inhibit protein synthesis (e.g. erythromycin and clarithromycin).
• Sulfonamides inhibit folic acid synthesis.
• Glycopeptides inhibit cell wall formation by inhibiting peptidoglycan synthesis;
vancomycin is the only glycopeptide approved for use in the U.S. Vancomycin-resistant
enterococci, vancomycin-intermediate S. aureus, and vancomycin-resistant S. aureus
have been isolated.
• Quinolones inhibit DNA activity by inactivating DNA gyrase. Newer agents are known as
fluoroquinolones (e.g., ciprofloxacin and levofloxacin).
• Polymyxins disrupt plasma membranes; they are used to treat infections caused by
gram-negative bacteria (e.g., polymyxin B and polymyxin E).
• Nitrofurantoin inhibits bacterial enzymes; nitrofurantoin is used to treat UTIs.
Alyazeed Hussein, BSc, SUST
This has been a presentation of Alyazeed Hussein
Thanks for your attention and kind patience
@elyazeed7
@Alyazeed7ussein

More Related Content

What's hot

Clostridium
ClostridiumClostridium
Clostridium
Rockstarvj009
 

What's hot (20)

Opportunistic fungal infection
Opportunistic fungal infectionOpportunistic fungal infection
Opportunistic fungal infection
 
CLOSTRITIUM (clostridia as human pathogens)
CLOSTRITIUM (clostridia as human pathogens)CLOSTRITIUM (clostridia as human pathogens)
CLOSTRITIUM (clostridia as human pathogens)
 
Streptococcus
StreptococcusStreptococcus
Streptococcus
 
Clostridium perfringens.pptx
Clostridium perfringens.pptxClostridium perfringens.pptx
Clostridium perfringens.pptx
 
Clostridium species
Clostridium species Clostridium species
Clostridium species
 
Haemophilus.pptx presntn
Haemophilus.pptx presntnHaemophilus.pptx presntn
Haemophilus.pptx presntn
 
Corynebacterium
CorynebacteriumCorynebacterium
Corynebacterium
 
Bordetella
BordetellaBordetella
Bordetella
 
Salmonella
SalmonellaSalmonella
Salmonella
 
Neisseria meningitidis
Neisseria meningitidisNeisseria meningitidis
Neisseria meningitidis
 
15. shigella
15. shigella15. shigella
15. shigella
 
Neisseria gonorrhoeae lecture iii term
Neisseria gonorrhoeae lecture iii termNeisseria gonorrhoeae lecture iii term
Neisseria gonorrhoeae lecture iii term
 
Shigella
ShigellaShigella
Shigella
 
Staphylococci ( gram positive cocci)
Staphylococci ( gram positive cocci)Staphylococci ( gram positive cocci)
Staphylococci ( gram positive cocci)
 
Clostridium
ClostridiumClostridium
Clostridium
 
Corynebacterium diptheriae(Microbiology)
Corynebacterium diptheriae(Microbiology)Corynebacterium diptheriae(Microbiology)
Corynebacterium diptheriae(Microbiology)
 
Syphilis and VDRL Test.pptx
Syphilis and VDRL Test.pptxSyphilis and VDRL Test.pptx
Syphilis and VDRL Test.pptx
 
Medical Microbiology Laboratory (streptococcus spp.)
Medical Microbiology Laboratory (streptococcus spp.)Medical Microbiology Laboratory (streptococcus spp.)
Medical Microbiology Laboratory (streptococcus spp.)
 
SALMONELLA
SALMONELLASALMONELLA
SALMONELLA
 
Medical Microbiology Laboratory (Neisseria spp.)
Medical Microbiology Laboratory (Neisseria spp.)Medical Microbiology Laboratory (Neisseria spp.)
Medical Microbiology Laboratory (Neisseria spp.)
 

Similar to Anaerobic Gram-Positive Spore-Forming Bacilli

Spore forming bacteria
Spore forming bacteriaSpore forming bacteria
Spore forming bacteria
sundu1
 
Spore forming bacteria
Spore forming bacteriaSpore forming bacteria
Spore forming bacteria
sundu1
 
A Brief PPT about Amoebiasis.pptx
A Brief PPT about Amoebiasis.pptxA Brief PPT about Amoebiasis.pptx
A Brief PPT about Amoebiasis.pptx
KunalGowda2
 
Clostridium .pptx gram-positive bacilli , clostridium tetani, clostridium pri...
Clostridium .pptx gram-positive bacilli , clostridium tetani, clostridium pri...Clostridium .pptx gram-positive bacilli , clostridium tetani, clostridium pri...
Clostridium .pptx gram-positive bacilli , clostridium tetani, clostridium pri...
husseinaweis87
 
Chapter_4_Pathogenic_Gram_positive_cocci.pptx
Chapter_4_Pathogenic_Gram_positive_cocci.pptxChapter_4_Pathogenic_Gram_positive_cocci.pptx
Chapter_4_Pathogenic_Gram_positive_cocci.pptx
AshenafiKochare
 
LINCOSAMIDES, GLYCOPEPTIDES AND OTHER ANTIBACTERIAL DRUGS.pptx
LINCOSAMIDES, GLYCOPEPTIDES AND OTHER ANTIBACTERIAL DRUGS.pptxLINCOSAMIDES, GLYCOPEPTIDES AND OTHER ANTIBACTERIAL DRUGS.pptx
LINCOSAMIDES, GLYCOPEPTIDES AND OTHER ANTIBACTERIAL DRUGS.pptx
Karthiga M
 
Bacteriology 4
Bacteriology   4Bacteriology   4
Bacteriology 4
sundu1
 
4 Staphylococci & Micrococci.pdf
4 Staphylococci & Micrococci.pdf4 Staphylococci & Micrococci.pdf
4 Staphylococci & Micrococci.pdf
drnuihi1
 
Anaerobic bacteria spring 2011
Anaerobic bacteria spring 2011Anaerobic bacteria spring 2011
Anaerobic bacteria spring 2011
Kayal Vizhi
 

Similar to Anaerobic Gram-Positive Spore-Forming Bacilli (20)

Clostridium microbacteria
Clostridium microbacteriaClostridium microbacteria
Clostridium microbacteria
 
Spore-forming gram Positive bacteria
Spore-forming gram Positive bacteriaSpore-forming gram Positive bacteria
Spore-forming gram Positive bacteria
 
Colysterdum
ColysterdumColysterdum
Colysterdum
 
Spore forming bacteria
Spore forming bacteriaSpore forming bacteria
Spore forming bacteria
 
Spore forming bacteria
Spore forming bacteriaSpore forming bacteria
Spore forming bacteria
 
A Brief PPT about Amoebiasis.pptx
A Brief PPT about Amoebiasis.pptxA Brief PPT about Amoebiasis.pptx
A Brief PPT about Amoebiasis.pptx
 
Clostridium tetani, botulinum, and difficile, by Dr. Himanshu Khatri
Clostridium tetani, botulinum, and difficile, by Dr. Himanshu KhatriClostridium tetani, botulinum, and difficile, by Dr. Himanshu Khatri
Clostridium tetani, botulinum, and difficile, by Dr. Himanshu Khatri
 
Neisseria
NeisseriaNeisseria
Neisseria
 
neisseria.pdf
neisseria.pdfneisseria.pdf
neisseria.pdf
 
Group b & d streptococci
Group b & d streptococciGroup b & d streptococci
Group b & d streptococci
 
Clostridium .pptx gram-positive bacilli , clostridium tetani, clostridium pri...
Clostridium .pptx gram-positive bacilli , clostridium tetani, clostridium pri...Clostridium .pptx gram-positive bacilli , clostridium tetani, clostridium pri...
Clostridium .pptx gram-positive bacilli , clostridium tetani, clostridium pri...
 
Gram negative bacilli (Enterobacteriaceae)
Gram negative bacilli (Enterobacteriaceae)Gram negative bacilli (Enterobacteriaceae)
Gram negative bacilli (Enterobacteriaceae)
 
Chapter_4_Pathogenic_Gram_positive_cocci.pptx
Chapter_4_Pathogenic_Gram_positive_cocci.pptxChapter_4_Pathogenic_Gram_positive_cocci.pptx
Chapter_4_Pathogenic_Gram_positive_cocci.pptx
 
LINCOSAMIDES, GLYCOPEPTIDES AND OTHER ANTIBACTERIAL DRUGS.pptx
LINCOSAMIDES, GLYCOPEPTIDES AND OTHER ANTIBACTERIAL DRUGS.pptxLINCOSAMIDES, GLYCOPEPTIDES AND OTHER ANTIBACTERIAL DRUGS.pptx
LINCOSAMIDES, GLYCOPEPTIDES AND OTHER ANTIBACTERIAL DRUGS.pptx
 
Bacteriology 4
Bacteriology   4Bacteriology   4
Bacteriology 4
 
4 Staphylococci & Micrococci.pdf
4 Staphylococci & Micrococci.pdf4 Staphylococci & Micrococci.pdf
4 Staphylococci & Micrococci.pdf
 
Kas ppt G+ve.pptx
Kas ppt G+ve.pptxKas ppt G+ve.pptx
Kas ppt G+ve.pptx
 
E.coli Dr. Mahadi
E.coli Dr. Mahadi E.coli Dr. Mahadi
E.coli Dr. Mahadi
 
BIOFILMS..pptx
BIOFILMS..pptxBIOFILMS..pptx
BIOFILMS..pptx
 
Anaerobic bacteria spring 2011
Anaerobic bacteria spring 2011Anaerobic bacteria spring 2011
Anaerobic bacteria spring 2011
 

More from Sijo A

More from Sijo A (20)

Microbial Biotechnology- Current trends
Microbial Biotechnology- Current trendsMicrobial Biotechnology- Current trends
Microbial Biotechnology- Current trends
 
AMR & Alternative Stratergies - Microbiology
AMR & Alternative Stratergies - MicrobiologyAMR & Alternative Stratergies - Microbiology
AMR & Alternative Stratergies - Microbiology
 
Medical Microbiology - Immunology
Medical Microbiology - ImmunologyMedical Microbiology - Immunology
Medical Microbiology - Immunology
 
General Characteristics of Viruses
General Characteristics of VirusesGeneral Characteristics of Viruses
General Characteristics of Viruses
 
Medical Microbiology - Bacteriology
Medical Microbiology - BacteriologyMedical Microbiology - Bacteriology
Medical Microbiology - Bacteriology
 
Medical Microbiology - Parasitology
Medical Microbiology - ParasitologyMedical Microbiology - Parasitology
Medical Microbiology - Parasitology
 
Medical Microbiology - Mycology
Medical Microbiology - MycologyMedical Microbiology - Mycology
Medical Microbiology - Mycology
 
Clinical Microbiology - Serology
Clinical Microbiology - SerologyClinical Microbiology - Serology
Clinical Microbiology - Serology
 
Clinical Microbiology Practical - 1
Clinical Microbiology Practical - 1Clinical Microbiology Practical - 1
Clinical Microbiology Practical - 1
 
DNA Viruses - Microbiology
DNA Viruses - MicrobiologyDNA Viruses - Microbiology
DNA Viruses - Microbiology
 
Aquatic Biofilm : Biotechnology
Aquatic Biofilm : Biotechnology Aquatic Biofilm : Biotechnology
Aquatic Biofilm : Biotechnology
 
History of plant pathology
History of plant pathologyHistory of plant pathology
History of plant pathology
 
Pathogen related proteins (Biotechnology)
Pathogen related proteins (Biotechnology)Pathogen related proteins (Biotechnology)
Pathogen related proteins (Biotechnology)
 
Classification of Fungi (Mycology)
Classification of Fungi (Mycology)Classification of Fungi (Mycology)
Classification of Fungi (Mycology)
 
Entamaoeba Histolytica (Exam Point of View)
Entamaoeba Histolytica (Exam Point of View)Entamaoeba Histolytica (Exam Point of View)
Entamaoeba Histolytica (Exam Point of View)
 
Plant taxonomic keys - Botany
Plant taxonomic keys - BotanyPlant taxonomic keys - Botany
Plant taxonomic keys - Botany
 
Human diseases caused by viruses
Human diseases caused by virusesHuman diseases caused by viruses
Human diseases caused by viruses
 
Mass Spectrometry Based Proteomics Analysis
Mass Spectrometry Based Proteomics AnalysisMass Spectrometry Based Proteomics Analysis
Mass Spectrometry Based Proteomics Analysis
 
Mass Spectrometry Based Proteomic Analysis
Mass Spectrometry Based Proteomic Analysis Mass Spectrometry Based Proteomic Analysis
Mass Spectrometry Based Proteomic Analysis
 
Webinar PCR - COVID-19, 2020
Webinar PCR - COVID-19, 2020Webinar PCR - COVID-19, 2020
Webinar PCR - COVID-19, 2020
 

Recently uploaded

Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
MedicoseAcademics
 

Recently uploaded (20)

CNN-based plastic waste detection system
CNN-based plastic waste detection systemCNN-based plastic waste detection system
CNN-based plastic waste detection system
 
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
MRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptxMRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptx
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)
 
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHYTUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 

Anaerobic Gram-Positive Spore-Forming Bacilli

  • 2. Clostridium perfringens (Clostridium welchii) • Gram reaction & characteristics: • Gram positive or gram variable bacilli, sore forming, obligate anaerobe, non-motile. brick-shaped rods/box car. Spores rarely seen. Spores are subterminal but difficult to induce. • Habitat: • Common inhabitant of the colon. • Virulence factor: • Produces several exotoxins; alphatoxin, the most important, mediates destruction of host cell membranes; enterotoxin inserts and disrupts membranes of mucosal cells; beta-toxin is a cytotoxin. Hemolysin, necrotizing toxin. • Disease: • Cellulitis, gas gangrene. • Alpha toxin (lecithinase) → muscle cell necrosis, degradative enzymes → subcutaneous gas bubbles → crepitus myonecrosis with crepitus (crackles), gangrenous muscles → black fluid exudate leaking from skin. • Post-abortion sepsis, abdominal infections, and enterocolitis, septicemia.
  • 3. • Major cause of food poisoning (from meats and gravy), resulting in a mild to moderate diarrhea without vomiting. • Enteritis necroticans (necrotizing enteritis; NEC): Life threatening infection that causes ischemic necrosis of the jejunum. • Diabetics and patients with circulatory disorders are more prone to infection. • Mode of transmission: • Bacteria are acquired through puncture wound or by ingestion. C. perfringens is normal flora of the GI tract and can spread from this site following trauma. • C. perfringens is also normal flora of the female genital tract and can cause post-abortion infections.
  • 4. • Lab diagnosis: • Samples: wound swabs, necrosed tissues, muscle fragments, exudates, pus, stool, food. • Culture characteristics: • Dome shape, glossy, dew drop, produces a double zone of beta-hemolysis on SBA or BRU/BA incubated anaerobically. • C. perfringens exhibits a positive (enhanced hemolysis) reverse CAMP test. In this assay, Streptococcus agalactiae (group B streptococci) is substituted for Staphylococcus aureus in the standard CAMP test. • Biochemical tests: • Positive: Positive for lecithinase and glucose, lactose, maltose, and fructose fermentation. Catalase negative. • Treatment: • Surgical removal of infected areas (amputation). • Hyperbaric oxygen to kill anaerobic organisms. • Penicillin, clindamycin (effective only in local, weak infections).
  • 5. • Nagler test: • Antilecithinase antibody is swabbed onto half of an egg yolk agar plate. The isolate is inoculated onto both halves of the plate. C. perfringens produces lecithinase, which will produce an opaque zone on the half of the plate without the antibody. The antibody will neutralize lecithinase, preventing the opaque zone from forming. This test is not performed much today.
  • 6.
  • 7. Clostridium tetani (drum-stick bacillus) • Gram reaction & characteristics: • Gram-positive bacilli with round/terminal spores that resemble drumsticks or tennis racket/lollipop obligate anaerobe, motile. Becomes gram neg after 24 hr. • Habitat: • Soil, dust, intestinal tract of various animal. • Virulence factor: • Produces tetanospasmin (TeNT), a neurotoxic exotoxin that disrupts nerve impulses to muscles. • Disease: • Spastic paralysis, tetanus (lock jaw or trismus), risus sardonicus (sneering): • C. tetani produces tetanospasmin, a neurotoxin that affects the anterior horn cells of the spinal cord, resulting in involuntary muscle contractions. Contractions begin with the neck and jaw ("lock jaw") and progress to a backward arching of the back muscles. • Mode of transmission: • Bacteria and spores gain entry into the host by puncture wounds contaminated with soil, or by wounds, which may include gunshots, burns, or animal bites. The bacteria produce little necrosis. Contamination of existing wound or puncture by objects contaminated with toxigenic Clostridium spp. • Drug injections. Human & animal bites.
  • 8. • Lab diagnosis: • Samples: excised bits of tissue from necrotic depths of wounds. Wounds swabs are not good. • Culture characteristics: • Colonies on BRU/BA are irregular and rhizoid, gray, matte, translucent, and usually with a narrow zone of -hemolysis. Often, a C. tetani colony swarms over the surface of a moist agar plate (proteus of anaerobe world). • Biochemical tests: • Positive: gelatinase, spot indole and motility positive. • Negative: catalase, lecithinase and lipase negative. • Treatment: • Clean wound • Antitoxin (human anti-tetanospasmin immunoglobulin) • DTaP vaccine booster • Penicillin, metronidazole • Diazepam (a GABA agonist). • Prophylaxis: • DTaP vaccine: tetanus toxoid, boosters required. • Note: • DTaP vaccines are administered at 2, 4, 6, and 18 months, again before starting school, and every 10 years thereafter. • Spores can affect neonates through cut umbilical cord, especially when the mother is not immunized.
  • 9. Body posture known as opisthotonos, caused by the neurotoxin tetanospasmin.
  • 10. Clostridium botulinum • Gram reaction & characteristics: • Gram positive or gram variable, bacilli, spore forming, obligate anaerobe, motile. Spores are oval/subterminal and resemble tennis rackets. • Habitat: • Soil, dust, water, vegetables, animals. • Virulence factor: • Botulinal toxin (BoNT), A, B, C, D, E, F ,G is a neurotoxin that binds to the synapse of nerve fibers (blocks acetylcholine release), resulting in acute (flaccid/rag doll) paralysis and death. • Disease: • Botulism. Flaccid paralysis and the four Ds: diplopia (double vision), dysarthria (speech disturbance), dysphonia (altered voice), and dysphagia (difficulty swallowing). • Adult botulism (classical food poisoning). Botulism due to ingestion of toxin in inadequately cooked or improperly canned foods. • Infant botulism/intestinal botulism (floppy baby syndrome). Infant botulism (due to ingestion of spores in honey) is the most common type of botulism. Bacteria are ingested and grow in the infant GI tract and can cause a rapidly fatal infection. • Wound botulism is the result of contamination of wounds with spores of C. botulinum, with subsequent germination, multiplication, and production of botulinal toxin in vivo. • No fever!
  • 11. • Mode of transmission: • Botulism is usually acquired by ingestions of spoiled, home-canned foods in which the spores are not destroyed. • Wound botulism from injection drug use. • Lab diagnosis: • Samples: stool, wounds specimen, food. • Botulinal toxin in serum, feces, gastric contents, vomitus, or the implicated food. • Toxicity in mice. • Culture characteristics: • On egg yolk agar (EYA), yellow precipitation, exhibit a pearly surface iridescence as a result of lipase positivity. • Biochemical tests: • Positive: Lipase, glucose, and motility. • Negative: lecithinase, spot indole, catalase. • Treatment: • Antitoxin, respiratory support. • Note: • Botulinum toxin has been applied successfully to treat a number of conditions, including strabismus, muscle spasticity, and facial wrinkles (Botox).
  • 12.
  • 13. Clostridium difficile • Gram reaction & characteristics: • Gram positive bacilli, may arrange in chains (2-6 cells) spore forming (subterminal), obligate anaerobe, motile. Brick-shaped bacilli • Habitat: • C. difficile is normal GI flora in a small percentage of the population, and as many as 30% of hospitalized patients may carry the bacteria. • Virulence factor: • toxin A (TcdA), enterotoxin → alters fluid secretion → watery diarrhea (AAD). • toxin B (TcdB), cytotoxic to epithelial cells → pseudomembranous colitis. • Disease: • Antibiotic treatment disrupts normal flora but C. difficile survives by forming spores. • Pseudomembranous Colitis (PMC), diarrhea (AAD). • Mode of transmission: • Person-to-person spread. • Spores of C. difficile are frequently transmitted among hospitalized patients and are often present on the hands of hospital personnel caring for patients.
  • 14. • Lab diagnosis: • Stool specimen: stool, toxin B present in feces. • Colonoscopy: pseudomembranes (yellow-white plaques) present. • Because C. difficile can be normal flora, stool cultures can sometimes be too sensitive. Cultures for C. difficile should only be performed on watery or unformed stools. • It is also important to test isolates for toxin production. • Samples: • Culture characteristics: • Non-hemolytic on BRU/BA. • Cycloserine-cefoxitin-fructose agar (CCFA) is used for isolating C. difficile from stool specimens, fructose positive, yellow flattened colonies. The product will also fluoresce yellow-green. • Biochemical tests: • Positive: glucose and fructose fermentation. • Negative: Lecithinase, lipase, catalase and spot indole. • Treatment: • Oral metronidazole or oral vancomycin. Withdraw causative antibiotic (often clindamycin). • Note: • Major cause of hospital-acquired diarrhea, often transmitted by the hands of hospital personnel. Inflammation by toxin A can sometimes cause hypoalbuminemia.
  • 15.
  • 17. Treponema pallidum • Characteristics: • Spirochetes, long, slender, helically curved bacilli, endoflagella, cannot usually be seen on Gram stain, microaerophilic, sensitive to high temperature. Special stains such as silver and Giemsa will stain spirochetes, silver for all spirochetes and Giemsa only for Borrelia. • Habitat: • Virulence factor: • Coat itself with host proteins. • Tropism to arterioles; infection ultimately leads to endarteritis (inflammation of the lining of arteries) and subsequent progressive tissue destruction. • Disease: • Venereal syphilis, 3 stages: • Primary: Chancre (painless ulcer) at the site of inoculation (genitalia). The primary stage is extremely infectious, because the lesion contains a large number of organisms. • Secondary: Skin rash and lesions on oral mucosa (fever, weight loss, malaise, and loss of appetite are present). Common symptoms are flulike (fever, sore throat, lymphadenopathy, Patchy hair loss may occur, such as loss of eyebrows (“moth-eaten” area). highly infectious state. Aseptic meningitis, • Latent: Absence of clinical symptoms (subclinical).
  • 18.
  • 19.
  • 20.
  • 21. • Tertiary: CNS disorders (neurosyphilis), aneurysms, and skin, liver, and bone disorders, cardiovascular abnormalities, eye disease, and granuloma-like lesions (gummas) that are soft, painless, and noninfectious and found on the skin or in the bones or visceral organs. • Congenital syphilis is transmitted from a mother to an unborn fetus during any stage of infection but is most often associated with early syphilis. The unborn fetus may develop an asymptomatic infection or symptomatic infection. • Symptoms known as Hutchinson triad (deafness, blindness, notched peg-shaped teeth) may occur. Additionally, poor bone formation may result, such as “saber shin” bowing of the tibia and the “bull dog” appearance of a deformed maxilla. Finally, neurosyphilis or neonatal death can occur. • Other clinically important species include T. pallidum subsp. pertenue (yaws), T. pallidum subsp. endemicum (endemic syphilis), and T. carateum (pinta). • Mode of transmission: • Transmitted by sexual contact, direct blood transmission, or transplacentally (congenital syphilis).
  • 22. • Lab diagnosis: • Spirochetes can be observed by darkfield or phase-contrast microscopy. • Samples: from ulcers, lesions, CSF, umbilical cord section, placenta. • chancer (containing live spirochetes), for primary syphilis diagnosis. • Serology: • Nontreponemal antigen tests include the Venereal Disease Research Laboratory (VDRL) and rapid plasma reagin (RPR) tests, which detect antibodies to cardiolipin- lecithin-cholesterol and are nonspecific. These antibodies are sometimes referred to as reagin. Biologic false positives are caused by Lyme disease, various viruses, autoimmune disorders (e.g., systemic lupus erythematosus), IM and pregnancy. • Treponemal antigen tests include the fluorescent treponemal antibody absorption (FT A-ABS) test and the Treponema pallidum particulate antigen (TP-PA) test, which are specific and confirmatory. • Direct fluorescent antibody tests can be used to detect T. pallidum in tissues and material obtained from primary or secondary lesions. • Culture characteristics: • T. pallidum cannot be cultured in the laboratory. The bacteria exhibit corkscrew motility seen by darkfield microscopy on material taken from lesions. • T. pallidum subsp. pallidum can be propagated in the testicles of live rabbits.
  • 23. Treatment: Penicillin G. Note: Organisms that cross placenta and therefore allow infection to pass from pregnant mother to fetus (TORCHES): TOxoplasma gondii Rubella Cytomegalovirus HErpes, HIV Syphilis
  • 24. Mycobacterium tuberculosis • Characteristics: • Gram positive, acid-fast bacilli, thin rods, non-motile, obligate aerobe. Mycolic acid cell wall: acid-fast staining, renders cell resistant to phagocytosis, germicides, and dryness. • Habitat: • Virulence factor: • Sulfatides in cell wall inhibit phagosome from fusing to lysosome, facultative I/C. • Disease: • Primary tuberculosis: • Infection begins in the middle or lower areas of the lungs. • The bacteria can spread (extrapulmonary tubercles) to the lymphatic system (scrofula), CNS, and heart (pericarditis), vertebral bodies (Pott’s disease), kidneys, GI. • Macrophages phagocytize the bacteria and form multinucleated cells, which are eventually surrounded by fibroid cells. Together the cells form granulomatous lesions called tubercles, which can be seen on chest X-rays. The lesions can calcify, at which point they are called "ghon complexes." While the bacteria are contained within the granulomas, the patient is typically asymptomatic. This stage of the disease is called a latent infection. • Primary TB may not lead to active TB in people with healthy immune systems. • Bloody sputum.
  • 25. • A mycolic acid in the cell walls of M. tuberculosis, called cord factor, is associated with several biologic activities, including host cell membrane cytotoxicity and inhibition of white blood cell migration. Serpentine cording Middlebrook 7H10
  • 26. • Reactivation or secondary tuberculosis: • Occurs in people who have had latent TB. • Dormant phase (macrophages) → mycolic acid cell wall allows intracellular survival and proliferation. Reactivation of pulmonary tubercles, may disseminate to other sites through lymphatics and blood (miliary TB), • Reactivation, because of alteration in the cell-mediated immune response, can be triggered by poor nutrition, alcoholism, or hormonal factors associated with pregnancy and diabetes. • Treatment requires long-term combination therapy, which can last up to 24 months. First-line drugs include isoniazid, rifampin, ethambutol, and pyrazinamide. • Mode of transmission: • Spread by person-to-person contact via infected droplets.
  • 27. special safety precautions must be practiced when working with mycobacteria • Negative-pressure room with air exiting through HEPA filters; • Biosafety cabinet. • Special centrifuges to contain aerosol production. • Protective clothing, such as masks, disposable gowns, gloves, caps, shoe protection, and sometimes, respirators. • Personnel should be monitored annually with the Mantoux tuberculin test (PPD), in which a mycobacterial antigen is injected into the skin.
  • 28. • Lab diagnosis: • Specimens: • Lower respiratory tract: Sputum and bronchial washings, usually 3 to 5 samples, are collected early in the morning on different days. • Urine: 3 to 5 different morning voids • Blood and bone marrow. • Tissue and body fluids. • It is necessary to decontaminate samples containing normal flora before culturing, and sputum must also be digested. • Digestion and decontamination of sputum samples: • The mycobacteria are slightly more resistant to acids and alkalis than contaminating bacteria making up the normal flora. Therefore, mild treatments, such as 2% NaOH with N-acetyl-L-cysteine (NALC), benzalkonium chloride, oxalic acid are effective. Only specimens containing normal flora, such as sputum that contains bacteria from the oral cavity or feces, urine, gastric lavage, need to be decontaminated. Specimens from normally sterile sites (e.g., CSF, blood, etc.) do not require decontamination. • NALC is a mucolytic agent that liquefies mucus in respiratory specimens, releasing mycobacteria. • NaOH is digestant and decontaminating agent, increases the pH to a level that is antibacterial.
  • 29. Centers for Disease Control and Prevention acid-fast smear evaluation and reporting criteria
  • 30. • Solid media: • Lowenstein-Jensen (LJ) contains egg components for growth and malachite green to inhibit growth of normal flora (nonpigmented (tan or buff, rough & tough), dry, heaped, and granular in 14-21 days at 37° C). • Lowenstein-Jensen-Gruft is made selective by the addition of penicillin and naladixic acid. It is also supplemented with RNA. • Middlebrook medium is agar based and contains 2% glycerol to support the growth of M. aviwn complex (MAC). These media generally exhibit growth several days before egg- based media. Antimicrobials can be added to make the media selective for the mycobacteria. • Liquid media: • Middlebrook 7H9 broth is often used to maintain stock cultures and prepare isolates for biochemical tests. • Mycobacterium growth index tube (MGIT®) by Becton Dickinson (Franklin Lakes, NJ) contains a modified 7H9 broth. The large amount of oxygen in the broth quenches the fluorescence of a fluorochrome. As mycobacteria grow, they consume the oxygen, and the fluorochrome will fluoresce when exposed to ultraviolet light. • BACTEC 460TB system contains a radioactively labeled substrate that can be metabolized by mycobacteria. Growth of mycobacteria releases radioactive CO2 that is detected by the instrument.
  • 31. +ve niacin accumulation test (right)
  • 32. • Acid-fast stain of sputum, PCR. • Purified protein derivative (PPD) test: DTH reaction in active or previous infection • Ghon complex on CXR. • Measure IFN-gamma released by lymphocytes exposed to M. tuberculosis antigens (e. g., Quantiferon Gold assay/IGRA). • Mycobacteria resist Gram staining because of lipids in their cell wall that prevent penetration of crystal violet and safranin. • Mycobacteria are acid-fast and are referred to as acid-fast bacilli (AFB). The primary stain in the acid-fast stain is carbol fuchsin. The Ziehl-Neelsen stain requires heating during the staining step, whereas the Kinyoun's stain does not. • M. tuberculosis is niacin positive, nitrate reduction positive, and 68°C catalase test negative. • Treatment: • Multidrug-resistant M. tuberculosis (MDR-TB), defined as simultaneous resistance to isoniazid and rifampin, was first discovered in 1991, and, if present, indicates a poor prognosis for recovery. • Extremely-drug-resistant M. tuberculosis (XDR-TB) is defined as resistance to any fluoroquinolone, and at least one of three injectable second-line drugs (capreomycin, kanamycin, and amikacin), in addition to isoniazid and rifampicin. • Treat with RIPES (multiple drugs to avoid resistance): rifampin, isoniazid, pyrazinamide, ethambutol, streptomycin prophylaxis (for +ve PPD). • BCG (Bacille Calmette-Guerin) vaccine: live attenuated vaccine for cell-mediated immunity, renders patient PPD +ve.
  • 33. • Mycobacterium avium complex (MAC) is comprised of two species that are difficult to distinguish, M. avium and M. intracellulare, collectively called Mycobacterium avium- intracellulare (MAI). • MAI infections are clinically indistinguishable from pulmonary and systemic tuberculosis infections. They are a major opportunistic pathogen in AIDS patients with low CD4 counts and are resistant to multiple drugs. • Treatment is with a macrolide ( azithromycin or clarithromycin) + ethambutol + rifamycin (rifampin or rifabutin). • M. bovis is found in unpasteurized milk and can lead to GI tuberculosis. Alternatively, it can lead to pulmonary tuberculosis if inhaled. • +ve PPD test: 10 mm induration (or 5 mm induration if immunocompromised, in AIDS often false-negative).
  • 34. • Runyon groups: • Photoreactivity: • 1) Photochromogens produce yellow to orange pigment only when exposed to light. • 2) Scotochromogens produce yellow to orange pigment in the light and in the dark. • 3) Nonchromogens (nonpigmented) do not produce pigment. • Growth rate: • Rapid growers produce colonies on solid media within 1 week. Most common pathogens are slow growers, and weakly pathogenic species are rapid growers. • Members of Runyon group 1 are slow growers and photochromogens. • Group 2 members are slow growers and scotochromogens. • Mycobacteria that are slow growers and nonchromogens belong to group 3. Group 4 contains the rapidly growing mycobacteria. Because of variation within the species, Runyon groups are no longer commonly used.
  • 35.
  • 36.
  • 37. • Niacin • Niacin (nicotinic acid) is a precursor in the synthesis of NAD. Although all mycobacteria produce niacin, some species produce an excess amount that is excreted from the cell. Niacin accumulates in the medium and is detected by reacting with a cyanogen halide. • M. tuberculosis is one of the few species positive for the accumulation of niacin. • Growth on MacConkey agar • MacConkey agar without crystal violet is inoculated with a 7-day broth culture of the test organism. This is not the same formulation used for gram-negative bacilli. • M. fortuitum and M. chelonei are the only mycobacteria able to grow on MacConkey agar in 5 days. • Susceptibility to thiophene-2-carboxylic acid hydrazide (T2H): differentiates M. bovis (susceptible) from most other species (resistant).
  • 38.
  • 40. Antimicrobials • An antibiotic is a molecule produced by microorganisms that inhibits the growth of other microorganisms. Antibiotics can also be synthetic. • Cidal: Kills microorganisms (e.g., bactericidal compound kills bacteria). • Static: Inhibits the growth of microorganisms (e.g., bacteristatic compound inhibits bacterial growth) • Synergy: When two or more antimicrobials are used, and the combined effect is greater than what would be expected for the simple additive effect of the agents. • Spectrum of Action: 1. Narrow-spectrum antimicrobial agent: Limited range of action 2. Broad-spectrum antimicrobial agent: Active against a wide range of bacteria.
  • 41. Classes of Antimicrobial Agents and Their Mode of Action • Beta-lactam antibiotics: • Inhibit cell wall synthesis. • (e.g., penicillins, cephalosporins, monobactams, and carbapenems). • Cephalosporin: • Narrow spectrum (first generation), • Expanded spectrum (second generation), • Broad spectrum (third generation), • Extended spectrum (fourth generation). • Beta-lactamase inhibitors: • Bacteria can exhibit resistance to the beta-lactam antibiotics by producing an enzyme (beta-lactamase) that cleaves the beta-lactam ring, inactivating the antibiotic. • Beta-lactamase inhibitors can be given with a beta-lactam antibiotic to provide effective treatment. Clavulanic acid, sulbactam, and tazobactam are examples of beta-lactamase inhibitors.
  • 42. • Aminoglycosides: • Inhibit protein synthesis at the 30S ribosomal subunit and are • Active against gram-negative and gram-positive bacteria • (e.g., gentamicin, tobramycin and netilmicin). Tobramycin is bactericidal whereas the others are bacteriostatic. • They have no activity against obligate anaerobes. • Because of potential toxicity, dosage should be monitored. • Tetracyclines: • Inhibit protein synthesis at the 30S ribosomal subunit. • (e.g., doxycycline and minocycline). • They are active against gram-positive and gram-negative bacteria and Mycoplasma and Chlamydia. • Increased resistance has limited their use.
  • 43. • Chloramphenicol inhibits protein synthesis by binding to the 30S ribosomal subunit. It is broad spectrum and used to treat serious gram-negative infections such as meningitis. Risk of bone marrow toxicity, aplastic anemia (bone marrow suppression), limits use to serious infections. • Macrolides inhibit protein synthesis (e.g. erythromycin and clarithromycin). • Sulfonamides inhibit folic acid synthesis. • Glycopeptides inhibit cell wall formation by inhibiting peptidoglycan synthesis; vancomycin is the only glycopeptide approved for use in the U.S. Vancomycin-resistant enterococci, vancomycin-intermediate S. aureus, and vancomycin-resistant S. aureus have been isolated. • Quinolones inhibit DNA activity by inactivating DNA gyrase. Newer agents are known as fluoroquinolones (e.g., ciprofloxacin and levofloxacin). • Polymyxins disrupt plasma membranes; they are used to treat infections caused by gram-negative bacteria (e.g., polymyxin B and polymyxin E). • Nitrofurantoin inhibits bacterial enzymes; nitrofurantoin is used to treat UTIs.
  • 44. Alyazeed Hussein, BSc, SUST This has been a presentation of Alyazeed Hussein Thanks for your attention and kind patience @elyazeed7 @Alyazeed7ussein